Humana Inc. (NYSE:HUM) Receives Average Rating of "Hold" from Brokerages

Key Points

• Humana Inc. has received an average rating of "Hold" from 20 brokerage firms, with one sell rating, twelve hold ratings, and seven buy ratings.
• The stock's average twelve-month target price is $293.33, reflecting varied analyst price targets ranging from $245 to $312.
• Humana recently declared a quarterly dividend of $0.885 per share, representing an annual yield of 1.2%.

Humana Inc. (NYSE:HUM - Get Free Report) has been assigned an average rating of "Hold" from the twenty ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $293.3333.

Several analysts have weighed in on HUM shares. Bank of America boosted their price target on Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a research note on Tuesday, September 2nd. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Evercore ISI assumed coverage on shares of Humana in a report on Monday, September 22nd. They issued an "in-line" rating and a $295.00 price target on the stock. Barclays decreased their price objective on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating for the company in a research note on Friday. Finally, Mizuho set a $300.00 price objective on shares of Humana in a report on Friday.

Institutional Trading of Humana

Hedge funds have recently modified their holdings of the stock. Cary Street Partners Investment Advisory LLC raised its position in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Applied Finance Capital Management LLC grew its stake in shares of Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after purchasing an additional 48 shares during the period. Blue Trust Inc. increased its holdings in shares of Humana by 3.6% during the 2nd quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider's stock valued at $334,000 after purchasing an additional 48 shares in the last quarter. Achmea Investment Management B.V. increased its holdings in shares of Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after purchasing an additional 49 shares in the last quarter. Finally, Beech Hill Advisors Inc. lifted its stake in shares of Humana by 6.1% in the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after purchasing an additional 50 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Up 4.3%

NYSE:HUM opened at $295.96 on Tuesday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana has a twelve month low of $206.87 and a twelve month high of $315.35. The company has a market cap of $35.60 billion, a PE ratio of 22.71, a P/E/G ratio of 1.67 and a beta of 0.42. The company's 50 day moving average is $276.06 and its two-hundred day moving average is $257.49.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter in the previous year, the firm posted $6.96 earnings per share. The company's quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts anticipate that Humana will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio (DPR) is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.